DoP Invites Applications for Young Professionals Across Key Divisions, Offers Rs 50,000 Monthly Pay Parthika Patel4 Dec 2025 8:30 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, has announced the engagement of Young Professionals (YPs)...
Coldrif case: ED attaches assets worth over Rs 2 crore of Sresan Pharma proprietor Ruchika Sharma4 Dec 2025 4:29 PM ISTNew Delhi: Directorate of Enforcement (ED), Chennai Zonal Office has made a major move against G. Ranganathan, the proprietor of Sresan...
Lupin enters into licensing agreement with Valorum for biosimilar Armlupeg in US Ruchika Sharma4 Dec 2025 2:14 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has entered into an Exclusive Licensing Agreement with Valorum Biologics, a ...
USFDA issues EIR for Zydus Jarod injectable facility Ruchika Sharma4 Dec 2025 1:14 PM ISTAhmedabad: Zydus has announced that the company has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug...
Granules India packaging facility in US successfully completes USFDA inspection Ruchika Sharma4 Dec 2025 12:52 PM ISTHyderabad: Granules India has announced that its US step-down subsidiary, Granules Consumer Health, a wholly-owned subsidiary of Granules...
USFDA-Telangana DCA meet to discuss future activities Ruchika Sharma4 Dec 2025 12:36 PM ISTHyderabad: Senior officials from the U.S. Food and Drug Administration (USFDA) recently held a meeting with the Drugs Control Administration,...
Eli Lilly Jaypirca secures USFDA approval for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor Ruchika Sharma4 Dec 2025 11:30 AM ISTIndianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has granted approval to Jaypirca...
Sandoz unveils denosumab biosimilars in Europe Ruchika Sharma4 Dec 2025 10:30 AM ISTBasel: Sandoz has announced the European launch of Wyost (denosumab 120 mg) and Jubbonti (denosumab 60 mg). The medicines are among the first...
Odisha ramps up drive against illegal sale of MTP kits Ruchika Sharma3 Dec 2025 6:23 PM ISTBhubaneshwar: In a major push to protect public health, the State Health and Family Welfare Department has intensified the state-wide drive on...
CDSCO Issues Risk Classification List for 187 Interventional Radiology Devices, Details Susmita Roy3 Dec 2025 5:31 PM ISTNew Delhi: In a move to streamline regulatory oversight of medical devices, the Central Drugs Standard Control Organisation (CDSCO) has released the...
DoP Invites Fresh PLI Scheme Applications for Meropenem, Ritonavir Manufacturing Parthika Patel3 Dec 2025 5:12 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has invited fresh applications for the manufacture of Meropenem and Ritonavir under the Production...
Lupin's Phase IV Report for Glycopyrronium, Vilanterol Inhalation Gets CDSCO Panel Nod Parthika Patel3 Dec 2025 5:02 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has accepted the Phase IV clinical trial...
